Federated Hermes
KURA icon

Federated Hermes’s Kura Oncology KURA Stock Holding History

Federated Hermes’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6K Buy
8,810
+638
+8% +$6.02K ﹤0.01% 1618
2026
Q1 		$66.4K Buy
+8,172
New +$70.2K ﹤0.01% 1650
2025
Q3 		– Sell
-291
Closed -$1.68K – 2179
2025
Q2 		$1.68K Buy
+291
New +$1.78K ﹤0.01% 1968
2022
Q1 		– Sell
-78,083
Closed -$1.09M – 2259
2021
Q4 		$1.09M Buy
+78,083
New +$1.26M ﹤0.01% 1240
2021
Q3 		– Sell
-117
Closed -$2K – 2278
2021
Q2 		$2K Sell
117
-18,600
-99% -$462K ﹤0.01% 2101
2021
Q1 		$529K Sell
18,717
-255,795
-93% -$8.09M ﹤0.01% 1552
2020
Q4 		$8.97M Sell
274,512
-3,049
-1% -$107K 0.02% 674
2020
Q3 		$8.5M Buy
277,561
+277,280
+98,676% +$6.12M 0.02% 606
2020
Q2 		$5K Buy
281
+195
+227% +$2.81K ﹤0.01% 1996
2020
Q1 		$1K Sell
86
-25,042
-100% -$287K ﹤0.01% 2117
2019
Q4 		$346K Sell
25,128
-194,362
-89% -$2.88M ﹤0.01% 1509
2019
Q3 		$3.33M Buy
219,490
+217,082
+9,015% +$3.86M 0.01% 877
2019
Q2 		$47K Buy
2,408
+2,246
+1,386% +$37.3K ﹤0.01% 1691
2019
Q1 		$3K Sell
162
-14
-8% -$216 ﹤0.01% 2033
2018
Q4 		$2K Buy
176
+130
+283% +$1.72K ﹤0.01% 2083
2018
Q3 		$1K Sell
46
-11,263
-100% -$216K ﹤0.01% 2201
2018
Q2 		$206K Sell
11,309
-2,082
-16% -$35.3K ﹤0.01% 1533
2018
Q1 		$251K Buy
13,391
+269
+2% +$5.24K ﹤0.01% 1487
2017
Q4 		$201K Buy
+13,122
New +$193K ﹤0.01% 1517

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Federated Hermes's KURA Position: Q2 2026 in Review

Federated Hermes increased its Kura Oncology (KURA) stake by 7.8% in Q2 2026, buying an estimated $6.02K and bringing the position to 8,810 shares worth $96.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

Federated Hermes first reported a position in KURA in Q4 2017 and has held it in 19 quarters since. The position peaked at $8.97M in Q4 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Federated Hermes held 8,810 shares of Kura Oncology worth $96.6K as of Q2 2026.
  • Federated Hermes bought 638 Kura Oncology shares in Q2 2026, an estimated $6.02K.
  • Kura Oncology made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1618 holding.
  • Federated Hermes first reported a position in Kura Oncology in Q4 2017 and has held it in 19 quarters since.
  • Federated Hermes's Kura Oncology position peaked at $8.97M in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.